Abstract |
A capacity of MF-2 synthetic microspheres to serve as the vehicle for transfer of the marker LacZ gene to mouse lung epithelial cells was studied after a single intranasal administration of the MF-2/gene complex. Two types of plasmids carrying marker gene LacZ were used in the experiments: with cytoplasmic (pCMV-LacZ) and nuclear (pCMV-nlsLacZ) localization of the gene product ( beta-galactosidase). As early as 7 days after the complexes MF-2/pCMV-LacZ and MF-2/pCMV-nlsLacZ were administered, specific staining for beta-galactosidase revealed this enzyme activity in the epithelial cells of bronchi, bronchioli, and alveoli. The maximum in vivo of the marker gene in the MF-2/pCMV-LacZ complex was observed at day 14 to 21 after administration and the corresponding gene product was detected during the following two months. The MF-2-mediated gene transfer led to a twofold increase in beta-galactosidase activity relative to the case when the "unbound" pCMV-LacZ plasmid was administered. These results suggest that the synthetic microsphere-mediated transfer of alien genes to the lung of experimental animals is promising. Microspheres may be used in gene therapy for pulmonary affections, in particular cystic fibrosis.
|
Authors | P B Glazkov, T E Ivashchenko, V A Sabetskiĭ, B Scholte, BaranovVS |
Journal | Genetika
(Genetika)
Vol. 36
Issue 5
Pg. 606-12
(May 2000)
ISSN: 0016-6758 [Print] Russia (Federation) |
Vernacular Title | Ekspressiia in vivo gena lacZ, dostavlennogo v legkie mysheĭ pri pomoshchi sinteticheskikh mikrosfer. |
PMID | 10867875
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Genetic Markers
- beta-Galactosidase
|
Topics |
- Administration, Intranasal
- Animals
- Epithelium
(metabolism)
- Gene Expression
- Genetic Markers
- Genetic Therapy
- Genetic Vectors
- Lac Operon
- Lung
(enzymology, metabolism)
- Mice
- Mice, Inbred C57BL
- Mice, Inbred CBA
- Microspheres
- Plasmids
- beta-Galactosidase
(genetics, metabolism)
|